Interact to see
Advertisement
Advertisement
ADNRX vs VMGMX
ADNRX vs VMGMX Comparison
Open Charts ADNRX vs VMGMX
ADNRX vs VMGMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. VMGMX commentary
Jun 15, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and VMGMX is a Buy.
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. ADNRX (160M). VMGMX pays higher dividends than ADNRX: VMGMX (0.62) vs ADNRX (0.00). ADNRX was incepted earlier than VMGMX: ADNRX (6 years) vs VMGMX (15 years). ADNRX (1.18) is less costly to investors than VMGMX (0.07). ADNRX is a more actively managed with annual turnover of: 46.00 vs. VMGMX (17.00). ADNRX has a lower initial minimum investment than VMGMX: ADNRX (0) vs VMGMX (3000). ADNRX annual gain was more profitable for investors over the last year : 22.76 vs. VMGMX (8.95). VMGMX return over 5 years is better than : 30.73 vs. ADNRX (-50.60).
| ADNRX | VMGMX | ADNRX / VMGMX | |
| Total Expense Ratio | 1.05 | 0.07 | 1,500% |
| Annual Report Gross Expense Ratio | 1.18 | 0.07 | 1,686% |
| Fund Existence | 6 years | 15 years | - |
| Gain YTD | -1.084 | 6.514 | -17% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 160M | 33.8B | 0% |
| Annual Yield % from dividends | 0.00 | 0.62 | - |
| Returns for 1 year | 22.76 | 8.95 | 254% |
| Returns for 3 years | 73.39 | 48.23 | 152% |
| Returns for 5 years | -50.60 | 30.73 | -165% |
| Returns for 10 years | N/A | 198.38 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LIDOX | 11.79 | 0.09 | +0.77% |
| Lord Abbett International Value F3 | |||
| PMARX | 13.03 | 0.07 | +0.54% |
| Victory Pioneer Equ Premium Income A | |||
| HAGCX | 49.36 | 0.20 | +0.41% |
| Carillon Eagle Mid Cap Growth C | |||
| CLBCX | 40.54 | 0.11 | +0.27% |
| American Funds American Balanced 529C | |||
| SWANX | 25.34 | -0.01 | -0.04% |
| Schwab Core Equity | |||